You K, Zhang XF, Zhao CL, Liu T, Guo DP. Clinical significance of expression of CHD5 in gastric carcinoma.
Shijie Huaren Xiaohua Zazhi 2012;
20:3317-3322. [DOI:
10.11569/wcjd.v20.i34.3317]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the expression of chromodomain helicase DNA-binding protein 5 (CHD5) mRNA and protein in gastric cancer, and to investigate the correlation between CHD5 expression and the development and progression of gastric cancer.
METHODS: Reverse transcription-polymerase chain reaction and immunohistochemistry were used to detect the expression of CHD5 mRNA and protein in 63 cases of gastric cancer tissues and 63 matched tumor-adjacent gastric tissues. The relationship between CHD5 expression and clinico-pathologic characteristics of gastric cancer was analyzed.
RESULTS: The expression level of CHD5 mRNA in gastric cancer tissues was significantly lower than that in matched tumor-adjacent gastric tissues (0.06 ± 0.04 vs 0.34 ± 0.06, t = 59.204, P < 0.01). The expression of CHD5 mRNA was significantly associated with histologic differentiation, TNM stage, and lymph node metastasis (all P < 0.05). The positive rate of CHD5 expression in gastric cancer tissues was significantly lower than that in matched tumor-adjacent gastric tissues (36.5% vs 71.4%, P < 0.01). The expression of CHD5 protein was correlated with histologic differentiation, TNM stage, and lymph node metastasis (all P < 0.05).
CONCLUSION: Low expression of CHD5 mRNA and protein in gastric carcinoma is related with tumor malignancy and invasiveness, suggesting that the tumor suppressor gene CHD5 may play an important role in the tumorigenesis and progression of gastric cancer.
Collapse